| Tumor-associated macrophages in human breast, colorectal, lung, ovarian and prostate cancers I Larionova, G Tuguzbaeva, A Ponomaryova, M Stakheyeva, ... Frontiers in oncology 10, 566511, 2020 | 270 | 2020 |
| Interaction of tumor-associated macrophages and cancer chemotherapy I Larionova, N Cherdyntseva, T Liu, M Patysheva, M Rakina, ... Oncoimmunology 8 (7), e1596004, 2019 | 261 | 2019 |
| Monocytes and macrophages as viral targets and reservoirs E Nikitina, I Larionova, E Choinzonov, J Kzhyshkowska International journal of molecular sciences 19 (9), 2821, 2018 | 209 | 2018 |
| Role of chitinase-like proteins in cancer J Kzhyshkowska, S Yin, T Liu, V Riabov, I Mitrofanova Biological chemistry 397 (3), 231-247, 2016 | 133 | 2016 |
| New angiogenic regulators produced by TAMs: perspective for targeting tumor angiogenesis I Larionova, E Kazakova, T Gerashchenko, J Kzhyshkowska Cancers 13 (13), 3253, 2021 | 85 | 2021 |
| Transcriptional, epigenetic and metabolic programming of tumor-associated macrophages I Larionova, E Kazakova, M Patysheva, J Kzhyshkowska Cancers 12 (6), 1411, 2020 | 79 | 2020 |
| Tumor-associated macrophages in human breast cancer produce new monocyte attracting and pro-angiogenic factor YKL-39 indicative for increased metastasis after neoadjuvant … T Liu, I Larionova, N Litviakov, V Riabov, M Zavyalova, M Tsyganov, ... Oncoimmunology 7 (6), e1436922, 2018 | 68 | 2018 |
| CD68+, but not stabilin-1+ tumor associated macrophages in gaps of ductal tumor structures negatively correlate with the lymphatic metastasis in human breast cancer M Buldakov, M Zavyalova, N Krakhmal, N Telegina, S Vtorushin, ... Immunobiology 222 (1), 31-38, 2017 | 60 | 2017 |
| Tumor-associated macrophages in human breast cancer parenchyma negatively correlate with lymphatic metastasis after neoadjuvant chemotherapy I Mitrofanova, M Zavyalova, N Telegina, M Buldakov, V Riabov, ... Immunobiology 222 (1), 101-109, 2017 | 49 | 2017 |
| Role of the immune component of tumor microenvironment in the efficiency of cancer treatment: perspectives for the personalized therapy M Stakheyeva, V Riabov, I Mitrofanova, N Litviakov, E Choynzonov, ... Current pharmaceutical design 23 (32), 4807-4826, 2017 | 45 | 2017 |
| Expression of M2 macrophage markers YKL-39 and CCL18 in breast cancer is associated with the effect of neoadjuvant chemotherapy N Litviakov, M Tsyganov, I Larionova, M Ibragimova, I Deryusheva, ... Cancer chemotherapy and pharmacology 82, 99-109, 2018 | 40 | 2018 |
| Возможности биомедицинского применения углеродных нанотрубок ИВ Митрофанова, ИВ Мильто, ИВ Суходоло, ГЮ Васюков Бюллетень сибирской медицины 13 (1), 135-144, 2014 | 29 | 2014 |
| Effect of early-stage human breast carcinoma on monocyte programming M Patysheva, I Larionova, M Stakheyeva, E Grigoryeva, P Iamshchikov, ... Frontiers in oncology 11, 800235, 2022 | 28 | 2022 |
| Monocyte programming by cancer therapy M Patysheva, A Frolova, I Larionova, S Afanas' ev, A Tarasova, ... Frontiers in Immunology 13, 994319, 2022 | 26 | 2022 |
| Radiotherapy resistance: identifying universal biomarkers for various human cancers I Larionova, M Rakina, E Ivanyuk, Y Trushchuk, A Chernyshova, ... Journal of Cancer Research and Clinical Oncology 148 (5), 1015-1031, 2022 | 24 | 2022 |
| The effect of neoadjuvant chemotherapy on the correlation of tumor-associated macrophages with CD31 and LYVE-1 I Mitrofanova, M Zavyalova, V Riabov, N Cherdyntseva, J Kzhyshkowska Immunobiology 223 (6-7), 449-459, 2018 | 23 | 2018 |
| SI‐CLP inhibits the growth of mouse mammary adenocarcinoma by preventing recruitment of tumor‐associated macrophages S Yin, N Wang, V Riabov, DM Mossel, I Larionova, K Schledzewski, ... International Journal of Cancer 146 (5), 1396-1408, 2020 | 22 | 2020 |
| Early-onset oral cancer as a clinical entity: aetiology and pathogenesis ES Kolegova, MR Patysheva, IV Larionova, IK Fedorova, DE Kulbakin, ... International journal of oral and maxillofacial surgery 51 (12), 1497-1509, 2022 | 21 | 2022 |
| YKL-39 as a potential new target for anti-angiogenic therapy in cancer J Kzhyshkowska, I Larionova, T Liu Frontiers in Immunology 10, 466351, 2020 | 21 | 2020 |
| Макрофаги и опухолевая прогрессия: на пути к макрофаг-специфичной терапии НВ Чердынцева, ИВ Митрофанова, МА Булдаков, МН Стахеева, ... Бюллетень сибирской медицины 16 (4), 61-74, 2017 | 19 | 2017 |
